DXC Falls 7% on Earnings. Shorts Stay Put.

DXC Technology reported on October 30 and dropped nearly 7% on the day, yet the short position barely moved, leaving the stock in an unusual place: a post-earnings selloff with no sign that bears are taking profits.

Short interest edged down 5% on the week to 15% of the free float, around 26.2 million shares, a gentle decline rather than a meaningful exit. The ORTEX short score has held in a tight range between 66 and 68 for the past two weeks, pointing to settled bearish conviction rather than any fresh push. Borrow conditions do nothing to pressure those shorts: cost to borrow is 0.45%, availability at 333%, meaning lenders hold more than three shares available for every two already on loan. That is a loose borrow market, and it gives shorts no reason to rush for the exit. Options traders are similarly unmoved. The put/call ratio of 0.35 is fractionally below its 20-day average of 0.36, a neutral reading that sits nowhere near the 52-week high of 1.14, so there is no hedging surge visible in the options market either.

The Street's reaction to earnings reinforces the cautious mood without tipping into alarm. JP Morgan's Tien-Tsin Huang raised his target to $13 on October 30 while maintaining an Underweight rating, a small upgrade that still implies the stock has further to fall from its $14.98 close. Susquehanna lifted its target to $12, also keeping a Neutral. The consensus mean target of $12.50 now sits below the current price, a rare configuration that reflects how far the October rally ran ahead of the fundamentals. The valuation metrics are genuinely cheap on paper: EV/EBITDA at 3.4x and a price-to-earnings ratio of just 5.3x, with the earnings yield factor ranked in the 91st percentile of the universe. Yet the EPS momentum scores, ranked 15th percentile over 30 days and 22nd over 90 days, tell you the market has not yet decided the earnings trough is in.

The most notable ownership development is a filing from BlackRock, which disclosed a stake of 16.2% in July, up from 12.7% previously. At nearly 28 million shares as of September 30, BlackRock is now the largest holder by a wide margin. American Century also added materially, building to 6.5% of shares as of the same date. Against that, Glenview Capital Management exited entirely, filing a 13G/A in August disclosing a move to 0% from 5.2%. No 13D activist is on the register, and no Schedule 13D has been filed on DXC. All stakes are as-last-disclosed around the 5% threshold, and a holder can fall below 5% without filing again.

On the alt data side, retail attention has spiked. Wikipedia views gave a z-score of 2.1 as of October 20, well above the stock's own 90-day history, which is consistent with the earnings event drawing fresh eyeballs. DXC's buyback spend was up 48% in Q2 versus the same quarter last year, though remaining authorization fell to a record low of $342 million in Q1 2026. Neither dataset has been measured to lead the company's reported figures, so they set context rather than signal anything about the next print. The next earnings event is scheduled for January 28, 2027, giving 89 days for the dust to settle.

Peers had a sharply different week. KD fell 6.3% alongside DXC, while EPAM and ACN gained 3.1% and 3.6% respectively, and GLOB added 3.8%. DXC's isolation from the broader IT services recovery is the clearest near-term signal in the data. What to watch next is whether shorts begin to cover now that the earnings catalyst has passed, or whether the gap between the $14.98 price and the $12.50 consensus target starts pulling the stock back toward where analysts think it belongs.